Blumenberg Robert M Md & Gelfand Michael Gloversville, NY - 12078

Blumenberg Robert M Md & Gelfand Michael is categorized under Doctors in Gloversville, NY and active since 1992.

Blumenberg Robert M Md & Gelfand Michael was established in 1992, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Roberrt Blumenburg at the company’s single location by writing to 99 East State St, Gloversville, New York NY 12078 or by phoning (518) 773-5675. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Blumenberg Robert M Md & Gelfand Michael
Contact Person: Roberrt Blumenburg
Address: 99 East State St, Gloversville, New York 12078
Phone Number: (518) 773-5675
Annual Revenue (USD): $100.000 to $499.999
Founded: 1992
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Blumenberg Robert M Md & Gelfand Michael was started in 1992 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Roberrt Blumenburg for inquiries that concern Blumenberg Robert M Md & Gelfand Michael by calling the company number (518) 773-5675, as your correspondence is most welcome. Additionally, the physical location of the single location of Blumenberg Robert M Md & Gelfand Michael can be found at the coordinates 43.068161,-74.330625 as well as the street address 99 East State St in Gloversville, New York 12078.

For its online presence, you may visit Blumenberg Robert M Md & Gelfand Michael’s website at and engage with its social media outlets through on Twitter and on Facebook.